Outsourcing
Mastering an Outsourcing Strategy
Relationship and Alliance Management in Outsourced Clinical Trials

How pharma and biotech sponsors approach their outsourcing strategy continues to adapt as the industry responds to business goals, technological advances, and patient needs. Outsourcing models, exploring new technologies and needs, as well as CRO and third-party provider relationships are being re-examined with an eye towards efficiency and adaptability. SCOPE’s 11th Annual Mastering an Outsourcing Strategy stream will dive into agile outsourcing models, working with technology vendors, and exploring the nuances of outsourcing for diversity and inclusion. SCOPE’s 12th Annual Relationship and Alliance Management for Clinical Trials stream is dedicated to exploring strategies for turning a failing relationship around, navigating challenges in acquisitions, and tackling operational challenges with outsourced partners. 





Monday, March 1

SCOPE'S 6TH ANNUAL MASTERS OF CLINICAL RESEARCH GOLF TOURNAMENT

Golf Check-In & Breakfast Buffet

SCOPE's 6th Annual Masters of Clinical Research Golf Tournament (Sponsorship Opportunities Available)*

Network on the greens at SCOPE's 6th Annual Golf Tournament!  Visit the SCOPE website for player and sponsorship opportunities. 
*Limited space available. Must be registered for SCOPE. Separate registration and fee required.

PRE-CONFERENCE WORKSHOPS, USER GROUPS, & NETWORKING EVENTS (IN-PERSON ONLY)

– 3:00pm Evinova Workshop

See the Workshops & User Groups page for details.

– 3:45 pm SCOPE'S Pickleball Networking Session: Paddles & Partnerships

Kick off the SCOPE 2027 conference with food, fun, and pickleball! Whether you're a pickleball pro or have never picked up a paddle, this event is perfect for everyone. Limited spots available. See the Workshops & User Groups page for details.

– 3:30 IQVIA Innovation Day

See the Workshops & User Groups page for details.

– 3:30 MAXIS AI Workshop

See the Workshops & User Groups page for details.

Registration Open

Golf Lunch Buffet (Sponsorship Opportunities Available)

Close of the Masters of Clinical Research Golf Tournament

Monday Plenary Keynote Session

MONDAY OPENING PLENARY: PATIENTS, SITES & THE FUTURE OF CLINICAL RESEARCH

Grab Your Seat: Early-Bird Seat Golden Ticket Raffle & Prize Giveaway!*

*Must be present to win.

Organizer's Welcome Remarks & 6th Annual Masters of Clinical Research Golf Tournament Awards and Jacket Signing

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: SCOPE's 4th Annual Site Innovation Awards

Irfan Khan, CEO, Circuit Clinical , CEO , Circuit Clinical

Amanda Wright, Co-Founder & Senior Vice President, Healthcare Alliance, Javara , Co-Founder & SVP , Healthcare Alliance , Javara

Panelists:

Karen Correa, PhD, Vice President, Development Operations, Boehringer Ingelheim , Vice President , Clinical Development Operations , Boehringer Ingelheim

Angela DeLuca, Vice President, Global Head, Site Management & Monitoring, AstraZeneca , VP & Global Head Site Management & Monitoring , Site Management & Monitoring , AstraZeneca

Joe Dustin, Senior Director, Digital Clinical Development, Sanofi , Senior Director, Digital Clinical Development , Digital Clinical Development , Sanofi

Sean Soth, Senior Vice President, Strategy and Global Business Partnerships, SCRS , Senior Vice President , Society for Clinical Research Sites (SCRS)

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: SCOPE's 11th Annual Participant Engagement Awards

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Kelly McKee, Vice President, Strategy & Transformation, Science 37; Co-Creator of the SCOPE Participant Engagement Award , Vice President, Strategy & Transformation , Science37

David Sall, President & CEO, Marketing, Patient Enrollment Advisors LLC; Co-Creator of the SCOPE Participant Engagement Award , President & CEO , Marketing , Patient Enrollment Advisors LLC

Panelists:

Andrea Bartucca, Director, Trial Awareness and Recruitment, Rapport Therapeutics , Director, Trial Awareness , Trial Awareness and Recruitment , Rapport Therapeutics

Sarah Bednarski, MS, Senior Director, Head Clinical Operations (ad interim), BlueRock Therapeutics , Sr. Director, Head Clinical Operations (ad interim) , Clinical Operations , BlueRock Therapeutics

Savine DaCosta, PhD, Clinical Trial Access and Representation Site Lead, Biogen , Clinical Trial Access and Representation Site Lead , Biogen

Anita Difrancesco, Senior Vice President, Clinical Operations, Endeavor Biomedicines , SVP , Clinical Operations , Endeavor Biomedicines

Gretchen Goller, Head, Recruitment and Retention, Pfizer Inc. , Head , Recruitment and Retention , Pfizer Inc.

April Lewis, Clinical Solutions, PatientPartner; Strategic Advisor, ZS , Sr. Director, Innovative Health , Global Development , Johnson & Johnson Innovative Medicine

Wendy Lurrie, Acting Head of Comms, BestGuessistan , Acting Head of Comms

Adrienne Walstrum, Senior Director, Global Trial Optimization, Merck , Senior Director , Global Trial Optimization , Merck & Co

Kate Wilson, Senior Director, Head of Global Clinical Trial Access & Representation, Biogen , Senior Director , Head of Global Clinical Trial Access & Representation , Biogen

KEYNOTE FIRESIDE CHAT: From Reform to Implementation: FDA’s New Clinical Trial Innovation Office and Operation Trialblazer

Kevin Bugin, PhD, Associate Vice President, Head, Global Regulatory Policy and Intelligence, Amgen , Head , Regulatory Policy and Intelligence , Amgen

Dianne Paraoan, Director, Office of Medical Policy, Office of New Drugs, CDER, FDA , Director , Office of Medical Policy, Office of New Drugs, CDER , FDA

FDA’s clinical-trial modernization agenda is moving from policy ambition to implementation. This plenary discussion will explore the new clinical-trial-innovation office being established within CDER’s Office of Medical Policy, Operation Trialblazer, and related FDA priorities. The conversation will focus on the office’s intended role, near-term priorities, opportunities to leverage existing industry capabilities, and what sponsors, sites, and research partners should anticipate as the work takes shape.

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: Solving the Enrollment Crisis: Bridging Clinical Care and Clinical Research

Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine , Executive Director and Professor, Tufts Center for the Study of Drug Development. , Tufts University School of Medicine

Panelists:

Nikki Amaratunge, Vice President, Clinical Development Operations, Head of Clinical Site Management, AbbVie, Inc. , VP Clinical Dev Operations , Head of Clinical Site Management , AbbVie

Susan Griffing, Vice President, Late Development Oncology Clinical Operations, AstraZeneca , VP, Clinical Operations - Late Stage Oncology , Late Development Oncology Clinical Operations , AstraZeneca

Elizabeth Rogers, Vice President, Head, R&D Clinical Operations, Portfolio Development, CSL Behring , VP , Head, R&D Clinical Operations, Portfolio Development , CSL Behring

Melinda M. Rottas, Vice President, Head of Optimization, Analytics & Recruitment Solutions, Pfizer Inc. , VP, Head of Optimization , Analytics & Recruitment Solutions , Pfizer Inc

SCOPE's Kickoff Reception—Welcome to the Wild Wild West! (Sponsorship Opportunities Available)

Saddle up and kick off SCOPE the right way! Reunite with friends, make new connections, and soak up the Florida vibes at a Wild Wild West showdown you won't want to miss.

Close of Day

Tuesday, March 2

TUESDAY MORNING EXERCISE & COFFEE

Sunrise Yoga: In Gratitude for Clinical Research Participants

Start your day with movement, mindfulness, and gratitude. Join us at sunrise for an all-levels yoga session honoring the invaluable contributions of clinical research participants. Led by a trained instructor, this restorative practice will focus on mindful movement, breath, and grounding—no experience necessary. Yoga begins at 6:30 am; mats and towels are provided.
Stay afterward for a complimentary breakfast and fitness-inspired gift! Proceeds from this event help support CISCRP's mission. 

Registration Link Coming Soon!

SCOPE's 5K Rise and Shine Fun Run! (Sponsorship Opportunities Available)

Lace up and start your SCOPE day on the move! Join SCOPE's Coordinators for the 5K Rise and Shin Fun Run/Walk. Run, jog, walk, or chat your way through the course—ALL abilities are welcome. It's a fun, informal way to get moving and connect with fellow attendees. Full details to come, so don't forget your sneakers! 

Registration Open

Get Up and Go Specialty Coffee (Sponsorship Opportunities Available)

Start your day with a little extra fuel! Grab made-to-order specialty coffee and sweet bites, courtesy of our sponsors.

Tuesday Morning Opening Plenary Keynotes

TUESDAY PLENARY: RETHINKING THE SPEED AND SHAPE OF CLINICAL DEVELOPMENT

Grab Your Seat—Early Bird Seat Raffle & Prize Giveaway!* (Sponsorship Opportunity Available)

Arrive early and you could leave a winner! Grab your seat and enter SCOPE’s Early Bird Seat Raffle for a chance to win an exciting prize. Don’t be late—*Must be present to win!

Welcome to SCOPE Europe 2027—Saddle up for the Future of Clinical Trials

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

KEYNOTE FIRESIDE CHAT: The Other Side of Drug Development: Pharma Leader's Journey as a Rare Disease Parent

Craig Lipset, Founder, Advisor, Clinical Innovation Partners; Co-Chair, Decentralized Trials & Research Alliance (DTRA) , Co Chair , Decentralized Trials & Research Alliance DTRA

Casey McPherson, CEO and Founder, AlphaRose Therapeutics , CEO and Founder , AlphaRose Therapeutics

Michelle Werner, Executive Vice President & President North America, Ipsen; Rare Disease Mom and Advocate , EVP , President, North America , Ipsen

For leaders who have spent their careers developing medicines, the experience of navigating a rare disease within their own family can bring an entirely different perspective to the urgency, complexity, and human impact of drug development. This fireside conversation will explore that intersection: what changes when an industry leader experiences drug development and clinical research as a parent, what the industry can learn from that perspective, and how it can inform the way we develop medicines and design clinical trials for patients and families.

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: From Years to Months: Is Radical Acceleration in Clinical Research Finally Possible?

Micky Cohen-Wolkowiez, MD, PhD, Executive Director, i-Cubed, Duke Clinical Research Institute , i-Cubed Executive Director , Duke Clinical Research Institute

Panelists:

Meghana Chalasani, Associate Director for Clinical Trial Innovation, Office of New Drugs, FDA CDER , Associate Director for Clinical Trial Innovation , Office of New Drugs , FDA CDER

Zhanna Jumadilova, MD, Biopharmaceutical Physician Executive, Pragmatic Clinical Trials, R&D, Pfizer Inc. , Pragmatic Trials Clinical Lead , Pragmatic Clinical Trials, R&D , Pfizer

Christoph Koenen, MD, Head of Clinical Development & Operations, Pharma R&D, Bayer , Head of Clinical Development & Operations , Pharma Research & Development , Bayer

Patrick Loerch, Senior Vice President, Clinical Data Science, Gilead Sciences , SVP Clinical Data Science , Clinical Data Science , Gilead Sciences

Michelle Werner, Executive Vice President & President North America, Ipsen; Rare Disease Mom and Advocate , EVP , President, North America , Ipsen

Grand Opening Coffee & Refreshment Break in the Exhibit Hall —Best of Show Voting Opens

Step into SCOPE’s one-of-a-kind exhibit hall! With 300+ leading clinical trial technology and service companies, it’s the place to discover new partners and reconnect with familiar ones. Cast your vote for SCOPE’s Best of Show, recharge with coffee, snap a photo, and don’t forget your comfy shoes—you’ll have miles to explore!

Part 1: Mastering an Outsourcing Strategy

Tuesday AM Tracks

HOW AI IS REDEFINING CLINICAL OUTSOURCING AND SPONSOR-VENDOR PARTNERSHIPS

Checklists to Agents in Site Contracting and Clinical Vendor Sourcing: How We Used AI to Modernize and Accelerate while Keeping It Human

Photo of Jenn Hill, Senior Director, Clinical Site Contracts and Payments, Vertex Pharmaceuticals , Senior Director , Clinical Site Contracts and Payments , Vertex Pharmaceuticals
Jenn Hill, Senior Director, Clinical Site Contracts and Payments, Vertex Pharmaceuticals , Senior Director , Clinical Site Contracts and Payments , Vertex Pharmaceuticals

Sandra O'Sullivan, Senior Director, Head, Clinical Vendor Management, Vertex Pharmaceuticals , Senior Director, Clinical Vendor Management , Vertex Pharmaceuticals

From checklists to agentic workflows, this talk explores how AI is helping modernize site contracting and clinical vendor sourcing without losing the human judgment that drives quality decisions. Learn how teams are using AI to streamline RFI/P development, summarize responses, build and analyze scorecards, assess budgets, support contract quality checks, and create clear decision-ready visuals across global study teams. We will also share emerging opportunities in budget comparison and internal training.

Closing the White Space in Fully Outsourced Clinical Trials: Using AI to Detect SOP Gaps, Clarify Accountability, and Strengthen Inspection Readiness

Photo of Anbu Damodaran, Associate Director, Statistical Programming, Alexion, AstraZeneca Rare Disease , Assoc Dir Statistical Programming , Statistical Programming , Alexion, AstraZeneca Rare Disease
Anbu Damodaran, Associate Director, Statistical Programming, Alexion, AstraZeneca Rare Disease , Assoc Dir Statistical Programming , Statistical Programming , Alexion, AstraZeneca Rare Disease

In fully outsourced clinical trials, CROs may conduct studies using their own SOPs while sponsors remain accountable for quality, compliance, participant safety, and data integrity. Even after sponsor review of CRO SOPs, audits and inspections may reveal workflow white space, unclear handoffs, or undefined roles. This presentation proposes an AI-assisted approach to compare sponsor and CRO SOPs, identify accountability gaps, and create risk-based oversight plans before compliance issues emerge.

Sponsored Networking Luncheon

Recharge, refuel, and connect over lunch—compliments of SCOPE sponsors! Enjoy a well-deserved break.

Networking Coffee & Dessert Break in the Exhibit Hall

Keep the conversations going in the Exhibit Hall with coffee and dessert, courtesy of SCOPE sponsors. Network with colleagues, explore new products and services, and don’t forget—Best of Show Award voting is still open, so be sure to cast your vote!

Tuesday PM Tracks

HOW AI IS REDEFINING CLINICAL OUTSOURCING AND SPONSOR-VENDOR PARTNERSHIPS (CONT.)

Panel Moderator:

PANEL DISCUSSION:
The New Engagement Landscape: Defining Service Categories and Aligning Vendor–Sponsor Expectations in the Age of AI

Rehbar Tayyabkhan, Head, R&D Sourcing & Procurement, Merck Research Labs , Head , R&D Sourcing & Procurement , Merck & Co

Panelists:

Jared Callan, Associate Director, Clinical Outsourcing, Jazz Pharmaceuticals , Associate Director , Jazz Pharmaceuticals

Gina Klayman, Head, Clinical Study Units, Americas, Sanofi , Head Clinical Study Units , Americas , Supplier Mgmt , Sanofi Grp

DATA, OVERSIGHT, AND PARTNERSHIPS: SHAPING THE FUTURE OF CLINICAL OUTSOURCING

Examining Sourcing Strategies and Their Relationship with Clinical Development Performance

Photo of Zachary Smith, Assistant Director, Data Sciences & Analytics, Tufts Center for the Study of Drug Development , Senior Data Scientist , Tufts Center for the Study of Drug Development
Zachary Smith, Assistant Director, Data Sciences & Analytics, Tufts Center for the Study of Drug Development , Senior Data Scientist , Tufts Center for the Study of Drug Development

This session presents results of a recently completed, definitive study conducted by Tufts CSDD. Robust quantitative data was collected and analyzed on more than a hundred clinical trials characterizing the primary outsourcing strategy (e.g., full service, individual, and multi-functional service) and its relationship with clinical trial speed, quality, and cost.

Beyond the CRO Contract: Sponsor Accountability and Oversight in Risk-Based Quality Management under ICH GCP E6 (R3)

Photo of Anirban Roy Chowdhury, Associate Vice President & Head, Development Centre of Excellence, Innovative Medicine, Sun Pharma , Assoc VP & Head , Development Centre of Excellence, Innovative Medicine , Sun Pharmaceutical Industries Ltd
Anirban Roy Chowdhury, Associate Vice President & Head, Development Centre of Excellence, Innovative Medicine, Sun Pharma , Assoc VP & Head , Development Centre of Excellence, Innovative Medicine , Sun Pharmaceutical Industries Ltd

As ICH GCP E6 (R3) reinforces that accountability for trial quality, participant safety, and data integrity remains with the sponsor, effective oversight of CROs and other third-party service providers has become a critical regulatory expectation. This session will explore evolving requirements for sponsor oversight within a risk-based quality management framework, including governance structures, risk identification and assessment, vendor qualification and management, performance monitoring, issue escalation, and documentation practices. Attendees will gain practical, inspection-ready approaches to strengthening oversight, enhancing transparency, fostering proactive risk management, and maintaining continuous visibility into study execution, quality, compliance, and participant protection.

Welcome Reception in the Exhibit Hall

Raise a glass and celebrate Day 1 of SCOPE! Reconnect with friends, meet new colleagues, and enjoy drinks with exhibitors at the Welcome Reception in the Exhibit Hall. Enter to win fabulous raffle prizes (must be present to win), then keep the evening going with dinner at Rosen Shingle Creek’s restaurants—no Orlando traffic required!

Close of Day

SCOPE Out the Restaurants and Shops at Pointe Orlando, via Our Courtesy Shuttle* (Sponsorship Opportunities Available)

Enjoy an evening exploring the restaurants and shops at Pointe Orlando with transportation provided by our courtesy shuttle. Shuttles will run until 11:00 pm, with the last pick-up at 10:30 pm.

*Times subject to change. More details closer to the event.​

Wednesday, March 3

Sunrise Yoga: In Gratitude for Clinical Research Participants

Start your day with movement, mindfulness, and gratitude. Join us at sunrise for an all-levels yoga session honoring the invaluable contributions of clinical research participants. Led by a trained instructor, this restorative practice will focus on mindful movement, breath, and grounding—no experience necessary. Yoga begins at 6:30am; mats and towels are provided. Stay afterward for a complimentary breakfast and fitness-inspired gift!  Proceeds from this event help support CISCRP's mission. 

Registration Link Coming Soon!

Registration Open

Wednesday Sponsored Breakfasts

BREAKFAST PRESENTATIONS

– 9:00 am In-Person Only Working Group Breakfast (Invitation Only)

Transition to Sessions

Wednesday AM Tracks

FROM VENDOR MANAGEMENT TO ECOSYSTEM ORCHESTRATION

Panel Moderator:

PANEL DISCUSSION:
Building High-Performing Clinical Development Ecosystems for the Next Generation of Outsourcing Models

Ailsa Mendez-Fitzwilliam, Business Development Executive, Syneos Health , Bus Dev Exec , Bus Dev , Syneos Health

As clinical development grows more complex, success depends on orchestrating an ecosystem of strategic partners rather than managing individual vendors. This panel discussion brings together perspectives from sponsor, CRO, and technology partner to explore how collaboration, governance, AI, data, and patient-centric innovation are reshaping clinical trial delivery. Panelists will share practical approaches for building integrated partnerships that accelerate decision-making, improve trial execution, and generate higher-quality evidence across the development lifecycle.

Coffee Break in the Exhibit Hall (Sponsorship Opportunities Available)

Refuel, reconnect, and make the most of your time in the Exhibit Hall! Grab a cup of coffee, visit booths you haven’t explored, and connect with colleagues and exhibitors. It’s your final chance to cast your vote for SCOPE’s Best of Show Award—make your vote count!

Part 2: Relationship and Alliance Management in Outsourced Clinical Trials

Wednesday Mid AM Tracks

Presentation to be Announced

Sponsored Networking Luncheon

Recharge, refuel, and connect over lunch—compliments of SCOPE sponsors! Enjoy a well-deserved break.

Networking Coffee & Dessert Break in the Exhibit Hall (Sponsorship Opportunities Available)—Best of Show Winner to be Announced

Recharge, reconnect, and satisfy your sweet tooth! Grab coffee and a treat, courtesy of our sponsors, then visit Game Card Sponsors to collect stickers and connect with colleagues before the afternoon sessions.  And don't miss the big reveal-the Best of Show winner will be announced during the break!

Wednesday PM Tracks

FROM WORKFORCE STRATEGY TO OUTSOURCING STRATEGY: THE IMPACT OF AI

FIRESIDE CHAT: Back to the Future: The AI Workforce—Then, Now, and Next

Photo of Jimmy Bechtel, Chief Site Success Officer, Society for Clinical Research Sites (SCRS) , Chief Site Success Officer , Society for Clinical Research Sites (SCRS)
Jimmy Bechtel, Chief Site Success Officer, Society for Clinical Research Sites (SCRS) , Chief Site Success Officer , Society for Clinical Research Sites (SCRS)
Photo of Rosalie Filling, Vice President, Senior Global Head, R&D Operations, Keenova Therapeutics , VP Clinical Operations , Clinical Operations , Keenova Therapeutics
Rosalie Filling, Vice President, Senior Global Head, R&D Operations, Keenova Therapeutics , VP Clinical Operations , Clinical Operations , Keenova Therapeutics
Photo of Max Ghez, Global Head, Clinical Business Development, Syneos Health , Global Head, Business Development , Syneos Health
Max Ghez, Global Head, Clinical Business Development, Syneos Health , Global Head, Business Development , Syneos Health
Photo of Scott Sawicki, Senior Director, Strategic Sourcing & Vendor Management, Centessa Pharmaceuticals , Senior Director , Strategic Sourcing & Vendor Management , Centessa Pharmaceuticals
Scott Sawicki, Senior Director, Strategic Sourcing & Vendor Management, Centessa Pharmaceuticals , Senior Director , Strategic Sourcing & Vendor Management , Centessa Pharmaceuticals
Photo of John Woodson, Executive Director, Head, Budget & Resource Management, Global Clinical Operations, Novartis , Executive Director, Head of Budget & Resource Management , Novartis Global Clinical Operations , Novartis Pharmaceuticals
John Woodson, Executive Director, Head, Budget & Resource Management, Global Clinical Operations, Novartis , Executive Director, Head of Budget & Resource Management , Novartis Global Clinical Operations , Novartis Pharmaceuticals

Transition to Plenary Keynote

Wednesday Afternoon Plenary

WEDNESDAY PLENARY: THE DIGITAL TRANSFORMATION OF CLINICAL TRIALS

Organizer's Welcome Remarks

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: The Digital Transformation of Clinical Trials: From Protocol to Patient

Darren Weston, Head, Integrated Data Analytics and Reporting, Johnson & Johnson , Head , Integrated Data Analytics and Reporting , Johnson & Johnson

Panelists:

Michael Cantor, Vice President, Data Technology & Innovation, Regeneron Pharmaceuticals, Inc. , Vice President , Data Technology & Innovation , Regeneron Pharmaceuticals Inc

Justine Rochon, Senior Vice President, Head of R&D Data and Quantitative Sciences, Takeda , SVP , Head of R&D Data and Quantitative Sciences , Takeda

Sammi Rui Tang, PhD, Senior Vice President & Global Head, Quantitative Sciences & Evidence Generation, Astellas Pharma, Inc. , Sr VP & Global Head , Quantitative Sciences & Evidence Generation , Astellas Pharma Inc

Rachel Nering, Vice President, Head of Early Development and eDevelopment, Sanofi , VP , Head of Early Development and eDevelopment , Sanofi

SCOPE's Closing Booth Crawl (Sponsorship Opportunities Available) & Last Chance for Exhibit Viewing

One last trip through the Exhibit Hall! Join SCOPE's Booth Crawl for food, drinks, networking, and one final chance to explore the exhibits and connect with sponsors and colleagues. Be sure to visit your must-see booths and enter the raffle for a chance to win (must be present to win)-let's finish SCOPE strong!

Close of Day

SCOPE Out the Restaurants and Shops at Pointe Orlando, via Our Courtesy Shuttle* (Sponsorship Opportunities Available)

Enjoy an evening exploring the restaurants and shops at Pointe Orlando with transportation provided by our courtesy shuttle. Shuttles will run until 9:00 pm, with the last pick-up at 8:30 pm.

*Times subject to change. More details closer to the event.

Thursday, March 4

Registration Open

BREAKFAST PRESENTATION

Transition to Sessions

DOING MORE WITH LESS: RESOURCING, OUTSOURCING, AND BIOTECH CLINICAL TRIALS STRATEGY

Big Trials, Small Teams: Innovative Resourcing Models to Deliver Phase 3 Excellence

Photo of Liza Micioni, Senior Director, Head of Clinical Operations, Tris Pharma , Senior Director, Head of Clinical Operations , Tris Pharma, Inc.
Liza Micioni, Senior Director, Head of Clinical Operations, Tris Pharma , Senior Director, Head of Clinical Operations , Tris Pharma, Inc.

Advancing a Phase 3 clinical program within a small biotech requires a fundamentally different operating model than that of large pharmaceutical organizations. This session explores practical and innovative approaches to maximizing limited resources, leveraging strategic partnerships, building agile teams, and prioritizing high-value activities. Attendees will learn how creative thinking, cross-functional collaboration, and disciplined decision-making can enable small biotechs to execute large, complex trials without compromising quality, timelines, or patient experience.

Panel Moderator:

PANEL DISCUSSION:
Real Talk: The Changing Truths of Outsourcing Partnerships in 2027 and Beyond

Photo of Caroline Redeker, Chief Commercial Officer, StuffThatWorks , Chief Commercial Officer , StuffThatWorks
Caroline Redeker, Chief Commercial Officer, StuffThatWorks , Chief Commercial Officer , StuffThatWorks

Innovation in clinical development demands agility, yet traditional vendor management often relies on rigid checklists, long vendor approval processes, and KPIs. Small biotechs and large pharmas alike must navigate distinct operational hurdles, from securing dedicated resource allocation to streamlining multi-provider workflows. How can sponsors build CRO/FSP relationships that deliver true strategic alignment, including how to integrate other providers? This expert panel explores how forward-thinking sponsors are reimagining vendor selection and governance. Panelists will share insights on how innovation is moving fast and changing the game, how you adapt internally or alongside your partners, and how to create an environment for the best operational performance on your programs.

Interactive Breakouts and Working Groups

INTERACTIVE WORKING GROUPS (IN-PERSON ONLY)

Find Your Working Group

Interactive Working Groups (Sponsorship Opportunity Available)

Step away from the slide decks and into the conversation.
After a full agenda of case studies, technical talks, and panels, SCOPE’s Interactive Working Groups offer a unique chance to roll up your sleeves and engage. Choose the topic that interests you—whether it aligns with your expertise or challenges you to think differently. Each group will explore a distinct theme using collaborative formats like hackathons, open innovation challenges, or problem-solving sprints. The only requirement: jump in and contribute.

Networking Coffee Break and Transition to Closing Keynote

Pause, connect, and get ready for the grand finale! Grab a cup of coffee, catch up with colleagues, and make a few final connections before heading into SCOPE’s Closing Keynote. It’s the perfect chance to recharge and refocus before we wrap up an incredible conference.

Closing Plenary Keynote

THURSDAY CLOSING PLENARY: REINVENTING R&D AND CLINICAL DEVELOPMENT

Organizer's Welcome Remarks

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute , Executive Director , Cambridge Healthtech Institute

KEYNOTE PRESENTATION: Case Study: AI and the R&D Revolution: Reinventing Drug Development from Discovery to Clinical Trials

Patrick Loerch, Senior Vice President, Clinical Data Science, Gilead Sciences , SVP Clinical Data Science , Clinical Data Science , Gilead Sciences

Dan Sheeran, Vice President & General Manager, Healthcare & Life Sciences, AWS , VP & GM Healthcare & Life , Healthcare & Life Sciences , AWS

AI is reshaping R&D from discovery through clinical development. This case study will explore how organizations are applying AI at scale to accelerate innovation, improve decision-making, and transform how new medicines are developed.

Panel Moderator:

KEYNOTE INTERACTIVE PANEL: The New Clinical Development Operating Model

Kristi Koontz, Vice President, Global Study and Site Operations, Amgen , VP , Global Study and Site Operations , Amgen

Panelists:

David Carruthers, Vice President, BioPharmaceuticals R&D Clinical Operations, AstraZeneca , Vice President , BioPharmaceuticals R&D Clinical Operations , AstraZeneca

Nick Hodges, Senior Vice President & Head, Clinical Development Operations & R&D Transformation Office, Ipsen , SVP, Head of Global Clinical Development , Global Clinical Operations , Ipsen

Henry Wei, MD, Executive Director, Development Innovation, Regeneron , Executive Director , Development Innovation , Regeneron Pharmaceuticals Inc

Community Luncheon and Last Hurrah

Wrap up SCOPE with closing remarks and lunch, courtesy of our sponsors! Enjoy your lunch here with us or grab it to go as you head out for the day. The poolside is calling.

Wrap up SCOPE with Closing Remarks and Lunch, Courtesy of Our Sponsors!

That’s a wrap! Thank you for joining us at SCOPE Summit 2027. We hope you leave inspired, connected, and energized by the conversations and ideas shared throughout the week. Safe travels, and we look forward to seeing you at the next SCOPE event!

Scope Summit 2027 Adjourns

#SCOPEsummit
SCOPE Track Summariese
SCOE Europe
SCOE Europe
Coming Soon - SCOPE X
SCOPE 365 ClinEco Connect
SCOPE of Things Podcast
Participant Engagement Award
Best of Show Award
Site Innovation Award
Join SCOPE LinkedIn Group
Event at a Glance
Media Partners
Attendee List
attendee profile

2027 Conference Programs

TRIAL DESIGN & PROTOCOL OPTIMIZATION

◆ Patient and Site Voice in Protocol Design

◆ Technology, Data and AI/ML for Intelligent Trial Design

FEASIBILITY & SITE STRATEGY

◆ Data-Driven Feasibility and Investigator Selection

◆ Tech and Collaboration to Streamline Start-Up and Reduce Site Burden

RECRUITMENT & ENGAGEMENT

◆ Enrollment Strategy and Trial Readiness

◆ Access, Trust, and Participant Engagement

SITE PARTNERING & OPERATIONS

◆ Building Strategic Sponsor-Site Partnerships

◆ Tech and Collaboration to Streamline Start-Up and Reduce Site Burden

BUDGETING & RESOURCES

◆ Clinical Trial Budgeting, Contracting, and Payments

◆ Clinical Trial Resource Management and Operational Planning

OUTSOURCING

◆ Mastering an Outsourcing Strategy

◆ Relationship and Alliance Management in Outsourced Clinical Trials

SCOPE BIOTECH FORUM

◆ Building Early-Stage Study Infrastructure

◆ Scaling Clinical Capabilities for Late-Stage Development

DATA

◆ Clinical Data Strategy

◆ Integrating AI into Clinical Data and Analytics

ADVANCING TRIAL DELIVERY

◆ Operational Excellence in Trial Execution

◆ Point-of-Care, Remote, and Decentralized Models

DIGITAL MEASURES & eCLINICAL TECHNOLOGIES

◆ Digital Endpoints and Biomarkers

◆ Digital Trials in a Connected Health Ecosystem

REAL WORLD EVIDENCE

◆ Accessing and Generating RWD

◆ Leveraging RWD for Clinical Research

AI IN CLINICAL RESEARCH

◆ Agentic AI in Clinical Research

◆ AI for Trial Optimization and Data Management

QUALITY & MONITORING

◆ Risk-Based Quality Management

◆ Central Monitoring and Signal Detection

SAFETY & PHARMACOVIGILANCE

◆ Building a Unified Safety Ecosystem

◆ Next-Generation Technologies and Intelligent Signal Detection

BIOSPECIMEN STRATEGY & OPERATIONS

◆ Modernizing Lab, Biospecimen & Data Management Operations

◆ Biomarker & Biospecimen Technology & Innovation

CLINICAL SUPPLY & LOGISTICS

◆ Communication & Digitization for End-to-End Clinical Supply Management

◆ Clinical Supply Chain Strategies to Align Process, Products, and Patients

THERAPEUTIC AREA SPOTLIGHTS

◆ CNS & Mental Health Trials

◆ Metabolic & Obesity Trials

◆ Oncology Trials

◆ Immunology & Inflammation Trials

INVESTOR CONFERENCE

◆ Clinical Trial Venture, Innovation & Partnering

PRE-CON EVENTS

◆ Monday Golf,  Opening Keynote with Site Innovation Awards & Participant Engagement Award

◆ SCOPE’s Opening Reception

◆ Pre-Con User Group & Workshops